Controlled treatment trials in the irritable bowel syndrome: A critique

Gastroenterology

Volumn 95, Issue 1, 1988, Pages 232-241

  Klein, Kenneth B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; LAXATIVE; OPIATE; PHENYTOIN; PLACEBO; SPASMOLYTIC AGENT; TIMOLOL; TRANQUILIZER;

CLINICAL TRIAL; HUMAN; IRRITABLE COLON; PRIORITY JOURNAL; REVIEW;

CLINICAL TRIALS; COLONIC DISEASES, FUNCTIONAL; HUMAN; RESEARCH DESIGN; SUPPORT, NON-U.S. GOV'T;

EID: 0023920461     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(88)90319-8     Document Type: Review

References (63)

1. Controlled clinical trial of mepiprazole in irritable bowel syndrome
2. Irritable colon syndrome treated with an antispasmodic drug
3. A double-blind trial of the effect of wheat bran on symptoms of irritable bowel syndrome
4. Treatment of the irritable bowel syndrome with Bentyl (dicyclomine hydrochloride)
5. A double-blind crossover study of diphenylhydantoin in irritable bowel syndrome
6. Comparison of the therapeutic effect of wheat bran, mebeverine, and placebo in patients with the irritable bowel syndrome
7. A three-part controlled study of trimebutine in the treatment of irritable colon syndrome
8. Clinical and functional evaluation of octilonium bromide in the treatment of irritable bowel syndrome: a double-blind controlled trial
9. Irritable colon and depression
10. Controlled clinical trial of sedative-anticholinergic drugs in patients with the irritable bowel syndrome
11. Oral domperidone: double blind comparison with placebo in irritable bowel syndrome
12. Role of loperamide and placebo in management of irritable bowel syndrome (IBS)
13. Preliminary report on antidepressant treatment of irritable bowel syndrome: comments on comparison with anxiolytic therapy
14. An assessment of dicyclomine hydrochloride (“Merbentyl”) in the irritable colon syndrome
15. A trial of trimebutine in spastic colon
16. Comparative effect of phenaglycodol, meprobamate, and a placebo on the irritable colon: a double-blind study
17. Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk
18. Double blind trial of ispaghula/poloxamer in the irritable bowel syndrome
19. Evaluation of tricyclic compound (trimipramine) vis-a-vis placebo in irritable bowel syndrome. (Double-blind randomized study)
20. A clinical trial of trimebutine (Mebutin) in spastic colon
21. Peppermint oil for the irritable bowel syndrome: a multicentre trial
22. Use of the peripheral dopamine antagonist, domperidone, in the management of gastro-intestinal symptoms in patients with irritable bowel syndrome
23. Etude côntrolée en double aveugle Duspatalin (mébévérine) contre placebo, dans le traitement du côlon irritable
24. Timolol treatment in the irritable bowel syndrome
25. Psyllium therapy in the irritable bowel syndrome: a double-blind trial
26. Domperidone treatment in the irritable bowel syndrome
27. Double blind trial of trimebutine in the irritable bowel syndrome
28. The two-period cross-over clinical trial
29. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial: survey of 71 “negative” trials
30. Statistics and ethics in medical research. III. How large a sample?
31. Some thoughts on clinical trials, especially problems of multiplicity
32. Impact of multiple comparisons in randomized clinical trials
33. Treating irritable bowel syndrome with peppermint oil
34. Therapeutic usefulness of amitriptyline in spastic colon syndrome
35. Effects of desipramine on irritable bowel syndrome compared with atropine and placebo
36. A controlled therapeutic study of the irritable bowel syndrome: effect of diphenylhydantoin
37. Mebeverine in patients with the irritable colon syndrome: double blind study
38. Diltiazem in the treatment of the irritable bowel syndrome
39. Prifinium bromide in the treatment of the irritable colon syndrome
40. Are anticholinergics of use in the irritable colon syndrome?
41. Physiological and clinical assessment of the effect ot the musculotropic agent mebeverine on the human colon
42. The effect of trimipramine in patients with the irritable bowel syndrome: a double-blind study
43. Loperamide treatment of the irritable bowel syndrome
44. Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity
45. Loperamide in treatment of irritable bowel syndrome—a double-blind placebo controlled study
46. Irritable bowel syndrome: an effective treatment?
47. Should I believe the results of this clinical trial?
48. Clinical evaluation of an anticholinergic in the irritable colon syndrome a double blind study of tricyclamol
49. The effect of coarse wheat bran in the irritable bowel syndrome A double-blind cross-over study
50. Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study
51. Double blind study of ispaghula in irritable bowel syndrome
52. Peppermint oil does not relieve the pain of irritable bowel syndrome
53. Irritable bowel syndrome: rational use of drugs